Solventum Corp reports results for the quarter ended March 31 - Earnings Summary

Solventum

08/05/2025 22:45

Solventum Corp SOLV.N reported quarterly adjusted earnings of $1.34​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of $2.08.  The mean expectation of nine analysts for the quarter was for earnings of $1.22 per share. Wall Street expected results to range from $1.15  to $1.31 per share.

Revenue rose 2.7% to $2.07 billion from a year ago; analysts expected $2.02 billion.

Solventum Corp's reported EPS for the quarter was 78 cents​.

The company reported quarterly net income of $137 million.

Solventum Corp shares had fallen by 13.9% this quarter and lost 0.9% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 7.3% in the last three months.​

In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 10 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "hold"

Wall Street's median 12-month price target for Solventum Corp is $80.00

This summary was machine generated from LSEG data May 8 at 09:45 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
1.22
1.34
Beat
Dec. 31 2024
1.32
1.41
Beat
Sep. 30 2024
1.39
1.64
Beat
Jun. 30 2024
1.51
1.56
Beat